Richard J-L, Mäusezahl M, Basler S, Eckert N. Approaching measles elimination in Switzerland: changing epidemiology 2007-2018. Swiss Med Wkly. 2019;149:w20102. doi:.https://doi.org/10.4414/smw.2019.20102
Schweizerischer Verein Homöopathischer Ärztinnen und Ärzte. Stellungnahme zu den Impfungen - Schweizerischer Verein Homöopathischer Ärztinnen und Ärzte (SVHA). 2 May 2019. www.svha.ch/uploaded/files/Stellungnahme_Impfungen_2019.pdf
Masserey Spicher V. Faktoren, welche Unterschiede in der Durchimpfung zwischen Kantonen in der Schweiz erklären: Ergebnisse der FEVAC-Studie (2014-2015). BAG Bulletin. 2018;9:12–21.
Vermeersch E. Individual rights versus societal duties. Vaccine. 1999;17(Suppl 3):S14–7.
MacDonald NE, Harmon S, Dube E, Steenbeek A, Crowcroft N, Opel DJ, et al. Mandatory infant & childhood immunization: Rationales, issues and knowledge gaps. Vaccine. 2018;36(39):5811–8. doi:.https://doi.org/10.1016/j.vaccine.2018.08.042
Betsch C, Böhm R. Detrimental effects of introducing partial compulsory vaccination: experimental evidence. Eur J Public Health. 2016;26(3):378–81. doi:.https://doi.org/10.1093/eurpub/ckv154
Verger P, Fressard L, Collange F, Gautier A, Jestin C, Launay O, et al. Vaccine Hesitancy Among General Practitioners and Its Determinants During Controversies: A National Cross-sectional Survey in France. EBioMedicine. 2015;2(8):891–7. doi:.https://doi.org/10.1016/j.ebiom.2015.06.018
Benin AL, Wisler-Scher DJ, Colson E, Shapiro ED, Holmboe ES. Qualitative analysis of mothers’ decision-making about vaccines for infants: the importance of trust. Pediatrics. 2006;117(5):1532–41. doi:.https://doi.org/10.1542/peds.2005-1728
Brown KF, Long SJ, Ramsay M, Hudson MJ, Green J, Vincent CA, et al. U.K. parents’ decision-making about measles-mumps-rubella (MMR) vaccine 10 years after the MMR-autism controversy: a qualitative analysis. Vaccine. 2012;30(10):1855–64. doi:.https://doi.org/10.1016/j.vaccine.2011.12.127
Wolf U, Maxion-Bergemann S, Bornhöft G, Matthiessen PF, Wolf M. Use of complementary medicine in Switzerland. Forsch Komplement Med. 2006;13(Suppl 2):4–6. doi:.https://doi.org/10.1159/000093488
Simões-Wüst AP, Rist L, Dettling M. Self-reported health characteristics and medication consumption by CAM users and nonusers: a Swiss cross-sectional survey. J Altern Complement Med. 2014;20(1):40–7. doi:.https://doi.org/10.1089/acm.2012.0762
Klein SD, Torchetti L, Frei-Erb M, Wolf U. Usage of Complementary Medicine in Switzerland: Results of the Swiss Health Survey 2012 and Development Since 2007. PLoS One. 2015;10(10):e0141985. doi:.. Correction in: PLoS One. 2015;10(12):e0144676. doi:https://doi.org/10.1371/journal.pone.0141985
Holt D, Bouder F, Elemuwa C, Gaedicke G, Khamesipour A, Kisler B, et al. The importance of the patient voice in vaccination and vaccine safety-are we listening? Clin Microbiol Infect. 2016;22(Suppl 5):S146–53. doi:.https://doi.org/10.1016/j.cmi.2016.09.027
Evangelatos N, Satyamoorthy K, Brand A. Personalized health in a public health perspective. Int J Public Health. 2018;63(4):433–4. doi:.https://doi.org/10.1007/s00038-017-1055-5
Deml MJ, Notter J, Kliem P, et al. “We treat humans, not herds!”: A qualitative study of complementary and alternative medicine (CAM) providers' individualized approaches to vaccination in Switzerland. Social Science and Medicine. 2019 (in revision).
Bundesamt für Gesundheit BAG OFSP. Masernimpfung in der Schweiz im 2012: Resultate einer nationalen Bevölkerungsbefragung zum Thema Masern. BAG Bulletin. 2013;17:278–83.